Pharming Group (PHAR) Financial Statements

225 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently $915.52M. The company's EPS TTM is $0.185; its P/E ratio is 76.98; Pharming Group is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 377.18M	€ 307.75M	€ 245.32M	€ 205.62M	€ 225.46M
Gross Profit	€ 331.56M	€ 271.09M	€ 220.10M	€ 188.06M	€ 201.49M
Operating Income	€ 20.88M	€ -8.93M	€ -5.39M	€ 18.23M	€ 15.37M
EBITDA	€ 31.70M	€ 16.89M	€ 9.88M	€ 33.53M	€ 55.30M
Net Income	€ 2.86M	€ -12.26M	€ -10.55M	€ 13.67M	€ 18.13M
Balance Sheet
Cash & Short-Term Investments	€ 179.81M	€ 173.85M	€ 213.42M	€ 207.34M	€ 217.59M
Total Assets	€ 499.81M	€ 414.18M	€ 462.85M	€ 425.80M	€ 450.44M
Total Debt	€ 115.78M	€ 116.30M	€ 171.54M	€ 166.69M	€ 183.39M
Net Debt	€ -30.25M	€ 59.41M	€ 109.80M	€ -40.65M	€ -34.20M
Total Liabilities	€ 222.79M	€ 185.27M	€ 244.07M	€ 221.16M	€ 231.73M
Stockholders' Equity	€ 277.02M	€ 228.91M	€ 218.78M	€ 204.64M	€ 218.71M
Cash Flow
Free Cash Flow	€ 49.31M	€ -2.68M	€ -18.77M	€ 20.48M	€ 23.95M
Operating Cash Flow	€ 50.07M	€ -1.86M	€ -17.30M	€ 22.46M	€ 42.90M
Investing Cash Flow	€ 18.43M	€ 32.74M	€ -129.39M	€ 5.32M	€ -24.15M
Financing Cash Flow	€ 14.48M	€ -35.63M	€ -1.04M	€ -4.98M	€ -31.68M

Currency in EUR

Pharming Group Earnings and Revenue History

Income Statement >

Pharming Group Debt to Assets

Balance Sheet >

Pharming Group Cash Flow

Cash Flow >

Pharming Group Forecast EPS vs Actual EPS

Earnings >